Header Logo

Connection

PAUL HOPKINS to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications PAUL HOPKINS has written about Antibodies, Monoclonal.
PAUL HOPKINS
Connection Strength
0.178
Antibodies, Monoclonal
  1. Alirocumab efficacy in patients with double heterozygous, compound heterozygous, or homozygous familial hypercholesterolemia. J Clin Lipidol. 2018 Mar - Apr; 12(2):390-396.e8.
    View in: PubMed
    Score: 0.090
  2. Efficacy of alirocumab in 1191 patients with a wide spectrum of mutations in genes causative for familial hypercholesterolemia. J Clin Lipidol. 2017 Nov - Dec; 11(6):1338-1346.e7.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.